ARCHIVES

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Large Pregnancy Weight Gain Raises Risk For Breast Cancer

May 31, 2002

New Partnership To Guide National 5 A Day Program.

August 31, 2001

Stories On Proscar Cause Confusion In Prostate Cancer Prevention Trial

September 6, 1996

An Angel In heaven – Or How Rejected Grants Do and Don’t Get Reviewed

May 3, 1974

Et2’s Referral Guidelines

July 23, 1993

Lederle Scientists Report Powerful New Anticancer Agent

July 31, 1987